e-learning
resources
Munich 2014
Monday, 08.09.2014
Pulmonary hypertension: clinical management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Studying quality of life in PAH: Patient-reported outcome assessment and psychosocial evaluation in a 6 months follow-up
L. Halimi, N. Molinari, C. Briand, A. S. Gamez, N. Collin, I. Vachier, A. Bourdin (Montpellier, France)
Source:
International Congress 2014 – Pulmonary hypertension: clinical management
Session:
Pulmonary hypertension: clinical management
Session type:
Thematic Poster Session
Number:
2376
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Halimi, N. Molinari, C. Briand, A. S. Gamez, N. Collin, I. Vachier, A. Bourdin (Montpellier, France). Studying quality of life in PAH: Patient-reported outcome assessment and psychosocial evaluation in a 6 months follow-up. Eur Respir J 2014; 44: Suppl. 58, 2376
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Correlations between clinical variables and quality of life in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Examination about what determine quality of life (QOL) and the association between QOL and therapeutic intervention for patients with chronic thromboembolitic pulmonary hypertension (CTEPH)
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Prognostic value of outcome variables at follow-up in patients with PAH
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
A retrospective study of depressive illness in patients with pulmonary hypertension (PH) at a specialist centre
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Em
PH
asis-10 is associated with clinical outcome measures in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Quality of life in worsening and non-worsening PAH patient’s in a 1 year follow-up: What’s going on?
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015
Impact of pulmonary endarterectomy (PEA) on quality of life as assessed by CAMbridge Pulmonary Hypertension Outcome Review (CAMPHOR)
Source: Eur Respir J 2006; 28: Suppl. 50, 403s
Year: 2006
Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Effect of comprehensive pulmonary rehabilitation in patients with sarcoidosis
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1)
Year: 2013
Relation of the novel pulmonary hypertension emPHasis10 quality of life score to markers of disease severity
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Impact of macitentan on the health-related quality of life (HRQoL) in pulmonary arterial hypertension (PAH): Results from a long-term randomised controlled trial
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013
Responsiveness of the clinical COPD questionaire to pulmonary rehabilitation
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
Impact of pulmonary tuberculosis sequelae on functional status
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Impulse oscillometry measurements are correlated to quality of life in patients with pulmonary sarcoidosis
Source: International Congress 2014 – ILDs 1
Year: 2014
Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Asthma comorbidities, a place for pulmonary embolism
Source: Annual Congress 2013 –Asthma
Year: 2013
Translation and preliminary validation of the KBILD QOL questionnaire to Spanish
Source: International Congress 2014 – ILDs 6
Year: 2014
The responsiveness and validity of the CAMPHOR Utility Index
Source: Eur Respir J 2008; 32: 1513-1519
Year: 2008
Patient rated WHO functional class and psychological distress are strongly associated with dyspnoea in pulmonary hypertension
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept